Cargando…

Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.

Overexpression of the tumour suppressor gene p53 was investigated immunohistochemically in 96 primary gastric carcinomas and 26 corresponding metastatic perigastric lymph nodes. Abnormalities in p53 expression were found in 52 (54%) of the 96 primary carcinomas. Tumours stained positively for p53 fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakeji, Y., Korenaga, D., Tsujitani, S., Baba, H., Anai, H., Maehara, Y., Sugimachi, K.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968266/
https://www.ncbi.nlm.nih.gov/pubmed/8439509
_version_ 1782134702699708416
author Kakeji, Y.
Korenaga, D.
Tsujitani, S.
Baba, H.
Anai, H.
Maehara, Y.
Sugimachi, K.
author_facet Kakeji, Y.
Korenaga, D.
Tsujitani, S.
Baba, H.
Anai, H.
Maehara, Y.
Sugimachi, K.
author_sort Kakeji, Y.
collection PubMed
description Overexpression of the tumour suppressor gene p53 was investigated immunohistochemically in 96 primary gastric carcinomas and 26 corresponding metastatic perigastric lymph nodes. Abnormalities in p53 expression were found in 52 (54%) of the 96 primary carcinomas. Tumours stained positively for p53 frequently metastasised to lymph nodes (the metastatic rate: 85%) compared to findings in those with negative p53 staining (64%, P < 0.05). Ninety-two percent (24/26) of the malignant cells in the lymph nodes stained positively for p53. When the DNA ploidy pattern of the tumour was determined by flow cytometry, the aneuploid tumours in p53 positive and negative groups accounted for 69% and 45%, respectively (P < 0.05). Proliferative activity of the tumour, as measured by Ki-67 labelling, was significantly higher (30.6 +/- 12.0%) in the p53 positive group than that (25.1 +/- 10.7%) in the p53 negative group (P < 0.05). Thus, gastric cancer with a mutant p53 has high proliferative activity and metastasis to lymph nodes will probably occur. IMAGES:
format Text
id pubmed-1968266
institution National Center for Biotechnology Information
language English
publishDate 1993
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19682662009-09-10 Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Kakeji, Y. Korenaga, D. Tsujitani, S. Baba, H. Anai, H. Maehara, Y. Sugimachi, K. Br J Cancer Research Article Overexpression of the tumour suppressor gene p53 was investigated immunohistochemically in 96 primary gastric carcinomas and 26 corresponding metastatic perigastric lymph nodes. Abnormalities in p53 expression were found in 52 (54%) of the 96 primary carcinomas. Tumours stained positively for p53 frequently metastasised to lymph nodes (the metastatic rate: 85%) compared to findings in those with negative p53 staining (64%, P < 0.05). Ninety-two percent (24/26) of the malignant cells in the lymph nodes stained positively for p53. When the DNA ploidy pattern of the tumour was determined by flow cytometry, the aneuploid tumours in p53 positive and negative groups accounted for 69% and 45%, respectively (P < 0.05). Proliferative activity of the tumour, as measured by Ki-67 labelling, was significantly higher (30.6 +/- 12.0%) in the p53 positive group than that (25.1 +/- 10.7%) in the p53 negative group (P < 0.05). Thus, gastric cancer with a mutant p53 has high proliferative activity and metastasis to lymph nodes will probably occur. IMAGES: Nature Publishing Group 1993-03 /pmc/articles/PMC1968266/ /pubmed/8439509 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Kakeji, Y.
Korenaga, D.
Tsujitani, S.
Baba, H.
Anai, H.
Maehara, Y.
Sugimachi, K.
Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.
title Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.
title_full Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.
title_fullStr Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.
title_full_unstemmed Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.
title_short Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.
title_sort gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968266/
https://www.ncbi.nlm.nih.gov/pubmed/8439509
work_keys_str_mv AT kakejiy gastriccancerwithp53overexpressionhashighpotentialformetastasisingtolymphnodes
AT korenagad gastriccancerwithp53overexpressionhashighpotentialformetastasisingtolymphnodes
AT tsujitanis gastriccancerwithp53overexpressionhashighpotentialformetastasisingtolymphnodes
AT babah gastriccancerwithp53overexpressionhashighpotentialformetastasisingtolymphnodes
AT anaih gastriccancerwithp53overexpressionhashighpotentialformetastasisingtolymphnodes
AT maeharay gastriccancerwithp53overexpressionhashighpotentialformetastasisingtolymphnodes
AT sugimachik gastriccancerwithp53overexpressionhashighpotentialformetastasisingtolymphnodes